A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa

Clinical trial NCT00782340 · COMPLETED

Trial details

NCT number: NCT00782340
Sponsor: Chelsea Therapeutics
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic Neuropathy Primary Autonomic Failure Dopamine Beta Hydroxylase Deficiency

Start date: 2008-09-01
Primary completion: 2010-09-01
Enrollment: 263

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.